Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma

Introduction Pilocytic astrocytoma (PA) is the most common primary brain neoplasm in children and treated in curative intent with gross total resection (GTR). However, PA is rare in adults, resulting in limited knowledge on the natural clinical course. This study aimed to describe the clinical cours...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuro-oncology 2020-05, Vol.148 (1), p.187-198
Hauptverfasser: Mair, Maximilian J., Wöhrer, Adelheid, Furtner, Julia, Simonovska, Anika, Kiesel, Barbara, Oberndorfer, Stefan, Ungersböck, Karl, Marosi, Christine, Sahm, Felix, Hainfellner, Johannes A., Rössler, Karl, Preusser, Matthias, Widhalm, Georg, Berghoff, Anna S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Pilocytic astrocytoma (PA) is the most common primary brain neoplasm in children and treated in curative intent with gross total resection (GTR). However, PA is rare in adults, resulting in limited knowledge on the natural clinical course. This study aimed to describe the clinical course and identify prognostic factors of adult patients with PA. Methods 46 patients ≥ 18 years at diagnosis of PA and neurosurgical resection or biopsy between 2000 and 2018 were identified from the Neuro-Biobank of the Medical University of Vienna. In two cases with differing histopathological diagnosis at recurrence, DNA methylation analysis was performed using Illumina Infinium HumanMethylation850 BeadChip (850 k) arrays and the Molecular Neuropathology classifier. Clinico-pathological features were correlated with patient outcomes. Results Median age at diagnosis was 32.5 years (range: 19–75) and median Ki67 proliferation index was 2.8% (0.5–13.4%). Tumor location significantly correlated with resectability (p  40 and higher body mass index (BMI) were associated with impaired progression-free and overall survival (p 
ISSN:0167-594X
1573-7373
DOI:10.1007/s11060-020-03513-9